Amgen has announced that the FDA has approved the indication expansion of its drug Xgeva (denosumab) to include the treatment of multiple myeloma, adding to its previous indication for the prevention of skeletal-related...

The European Commission proposed on Wednesday joint clinical assessments to determine whether approved new drugs and medical devices offer value for money and should be prescribed for patients within national healthcare...

Companies expecting competition from Celgene multiple sclerosis candidate ozanimod just got a reprieve. The big biotech revealed that the FDA refused to accept its approval application because of “incomplete”...

Tagworks Pharmaceuticals, gevestigd in het Radboudumc, heeft een nieuwe techniek ontwikkeld om chemotherapie gericht af te geven bij tumoren waarbij dat tot dusver heel moeilijk bleek. Door de chemo gecontroleerd los te...

A surprise new name was thrown into the ring to take on Pfizer’s healthcare unit but speculation suggests that valuation is once again the sticking point, indicating that Pfizer may not be able to find anyone willing to...